Clearside Biomedical, Inc. (CLSD) Reports Q2 Loss, Lags Revenue Estimates

Clearside Biomedical, Inc. (CLSD) came out with a quarterly loss of $0.10 per share versus the Zacks Consensus Estimate of a loss of$ 0.14. This compares to loss of $0.15 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 28.57%. A quarter ago, it was expected that this company would post a loss of$ 0.14 per share when it actually produced a loss of $0.17, delivering a surprise of -21.43%. Over the last four quarters, the compan ...